新闻中心

新闻中心

News Center
All Categories
Company News
Industry News

Foncoo Pharmaceutical's NEEQ listing application was approved

Release Time

2022-06-22 10:32

On March 31, 2016, the company's application for stock listing on the National Equities Exchange and Quotations (commonly known as the New Third Board) was approved. Company stock abbreviation: Foncoo Pharmaceutical, stock code: 837090.

The company's successful application for listing on the New Third Board is of epoch-making significance for the company's development. It has improved the company's public image and recognition, and improved corporate governance and financial norms; it has broadened financing channels and can support the realization of the company's strategy to the greatest extent. .

 
 

Previous page

Eight Disciplines of Foncoo Pharmaceutical's "Integrity Culture" Work

Foncoo Pharmaceutical's 2015 Work Summary and Commendation Conference was successfully held

Next page

Previous page

Eight Disciplines of Foncoo Pharmaceutical's "Integrity Culture" Work

Next page

Foncoo Pharmaceutical's 2015 Work Summary and Commendation Conference was successfully held

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称
2021-Foncoo Public Welfare

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称
Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称
Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称
Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称